Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Melanoma, Mucosal Melanoma Challenges

Ryan Sullivan

MD

🏢Massachusetts General Hospital🌐USA

Director, Melanoma Program

44
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Ryan Sullivan specializes in rare melanoma subtypes including mucosal and acral lentiginous melanoma, which have limited responses to standard immunotherapy. His research has explored the molecular drivers and treatment vulnerabilities of KIT-mutant and NRAS-mutant melanomas. He has contributed to understanding resistance mechanisms to BRAF/MEK inhibitor therapy and strategies for overcoming adaptive resistance in metastatic melanoma.

Share:

🧪Research Fields 研究领域

mucosal melanoma treatment
acral lentiginous melanoma
KIT-mutant melanoma imatinib
BRAF negative melanoma immunotherapy
melanoma NRAS mutations

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Ryan Sullivan 的研究动态

Follow Ryan Sullivan's research updates

留下邮箱,当我们发布与 Ryan Sullivan(Massachusetts General Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment